Table 2.

Postoperative complications.

	Rivaroxaban group (n = 18)	Aspirin group (n = 14)	p-value
Local complications	No = 14 (77.8%)	No = 12 (85.8%)	0.803
	Dehiscence = 3 (16.7%)	Dehiscence = 1 (7.1%)
	Deep infection = 1 (5.5%)	Deep infection = 1 (7.1%)
Systemic complications	No = 18 (100.0%)	No = 13 (92.9%)	0.437
	Yes = 0 (0.0%)	Yes = 1 (7.1%)
DVT	No = 16 (88.9%)	No = 13 (92.9%)	1.000
	Yes = 2 (11.1%)	Yes = 1 (7.1%)
Hospital readmission	No = 16 (88.9%)	No = 12 (85.7%)	1.000
	Yes = 2 (11.1%)	Yes = 2 (14.3%)
Reoperation	No = 16 (88.9%)	No = 13 (92.9%)	1.000
	Yes = 2 (11.1%)	Yes = 1 (7.1%)
Death	No = 17 (94.4%)	No = 14 (100.0%)	1.000
	Yes = 1 (5.6%)	Yes = 0 (0.0%)

n, sample size; DVT, deep venous thrombosis.